Longeveron Inc. (LGVN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:38AM EDT. Market open.
| Previous Close | 1.5400 |
| Open | 1.5900 |
| Bid | 1.5400 x 100 |
| Ask | 1.6400 x 200 |
| Day's Range | 1.5401 - 1.5900 |
| 52 Week Range | 1.5150 - 40.0000 |
| Volume | |
| Avg. Volume | 2,160,701 |
| Market Cap | 9.744M |
| Beta (5Y Monthly) | 0.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)
Longeveron Inc (NASDAQ:LGVN), a biotechnology company specializing in the development of cellular therapies for aging-related and life-threatening conditions, has reported an insider purchase by a high-level executive.
- Simply Wall St.
Longeveron Full Year 2023 Earnings: EPS Misses Expectations
Longeveron ( NASDAQ:LGVN ) Full Year 2023 Results Key Financial Results Net loss: US$22.2m (loss widened by 18% from FY...
- Insider Monkey
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript February 27, 2024 Longeveron Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. FDS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, good afternoon, and […]
© 2024 Yahoo. All rights reserved.